These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 16621361)

  • 1. Zero-order release of aspirin, theophylline and atenolol in water from novel methylcellulose glutarate matrix tablets.
    Khairuzzaman A; Ahmed SU; Savva M; Patel NK
    Int J Pharm; 2006 Aug; 318(1-2):15-21. PubMed ID: 16621361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release.
    Nokhodchi A; Aliakbar R; Desai S; Javadzadeh Y
    Colloids Surf B Biointerfaces; 2010 Aug; 79(1):262-9. PubMed ID: 20451361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
    Zugasti ME; Zornoza A; Goñi Mdel M; Isasi JR; Vélaz I; Martín C; Sánchez M; Martínez-Ohárriz MC
    Drug Dev Ind Pharm; 2009 Oct; 35(10):1264-70. PubMed ID: 19555243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of ethanol on aspirin release from hypromellose matrices.
    Roberts M; Cespi M; Ford JL; Dyas AM; Downing J; Martini LG; Crowley PJ
    Int J Pharm; 2007 Mar; 332(1-2):31-7. PubMed ID: 17084050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of an extended-release matrix tablet using chitosan/Carbopol interpolymer complex.
    Park SH; Chun MK; Choi HK
    Int J Pharm; 2008 Jan; 347(1-2):39-44. PubMed ID: 17662544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of chitosan acetate as a binder for sustained release tablets.
    Nunthanid J; Laungtana-Anan M; Sriamornsak P; Limmatvapirat S; Puttipipatkhachorn S; Lim LY; Khor E
    J Control Release; 2004 Sep; 99(1):15-26. PubMed ID: 15342177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
    Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
    Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of theophylline and carbamazepine from matrix tablets--consequences of HPMC chemical heterogeneity.
    Viridén A; Abrahmsén-Alami S; Wittgren B; Larsson A
    Eur J Pharm Biopharm; 2011 Aug; 78(3):470-9. PubMed ID: 21316446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study on maize proteins as a potential new tablet excipient.
    Georget DM; Barker SA; Belton PS
    Eur J Pharm Biopharm; 2008 Jun; 69(2):718-26. PubMed ID: 18294824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations.
    Korang-Yeboah M; Rahman Z; Shah D; Mohammad A; Wu S; Siddiqui A; Khan MA
    Int J Pharm; 2016 Feb; 499(1-2):20-28. PubMed ID: 26688036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of source variation on drug release from HPMC tablets: linear regression modeling for prediction of drug release.
    Piriyaprasarth S; Sriamornsak P
    Int J Pharm; 2011 Jun; 411(1-2):36-42. PubMed ID: 21420475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets.
    Jug M; Bećirević-Laćan M
    Eur J Pharm Sci; 2004 Feb; 21(2-3):251-60. PubMed ID: 14757497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified drug release of poloxamer matrix by including water-soluble and water-insoluble polymer.
    Gonzalez YM; Ghaly ES
    Drug Dev Ind Pharm; 2010 Jan; 36(1):64-71. PubMed ID: 19747067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Swelling kinetics of spray-dried chitosan acetate assessed by magnetic resonance imaging and their relation to drug release kinetics of chitosan matrix tablets.
    Huanbutta K; Sriamornsak P; Limmatvapirat S; Luangtana-anan M; Yoshihashi Y; Yonemochi E; Terada K; Nunthanid J
    Eur J Pharm Biopharm; 2011 Feb; 77(2):320-6. PubMed ID: 21129484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermal and non-thermal methods to evaluate compatibility of granisetron hydrochloride with tablet excipients.
    Late SG; Banga AK
    Pharmazie; 2008 Jun; 63(6):453-8. PubMed ID: 18604989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices.
    Javadzadeh Y; Musaalrezaei L; Nokhodchi A
    Int J Pharm; 2008 Oct; 362(1-2):102-8. PubMed ID: 18647643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and evaluation of Ficus glomerata mucilage sustained release matrix tablets of gliclazide.
    Kumar CS; Reddy-Budideti KK; Battula SP; Ayyavala CS
    Pak J Pharm Sci; 2011 Jul; 24(3):399. PubMed ID: 21715275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymer mobilization and drug release during tablet swelling. A 1H NMR and NMR microimaging study.
    Dahlberg C; Fureby A; Schuleit M; Dvinskikh SV; Furó I
    J Control Release; 2007 Sep; 122(2):199-205. PubMed ID: 17706829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.